SwitchPoint Financial Planning’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Buy
738
+5
+0.7% +$1.85K 0.16% 54
2026
Q1
$214K Buy
733
+7
+1% +$2.3K 0.15% 63
2025
Q4
$254K Buy
726
+24
+3% +$8.11K 0.18% 53
2025
Q3
$227K Sell
702
-2
-0.3% -$622 0.16% 58
2025
Q2
$274K Buy
704
+9
+1% +$3.62K 0.22% 47
2025
Q1
$302K Buy
695
+5
+0.7% +$2.01K 0.29% 38
2024
Q4
$255K Buy
+690
New +$289K 0.24% 40

Other funds holding ELV

SwitchPoint Financial Planning's ELV Position: Q2 2026 in Review

SwitchPoint Financial Planning increased its Elevance Health (ELV) stake by 0.68% in Q2 2026, buying an estimated $1.85K and bringing the position to 738 shares worth $285K. The position accounts for 0.16% of the portfolio, ranked #54.

SwitchPoint Financial Planning first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $302K in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • SwitchPoint Financial Planning held 738 shares of Elevance Health worth $285K as of Q2 2026.
  • SwitchPoint Financial Planning bought 5 Elevance Health shares in Q2 2026, an estimated $1.85K.
  • Elevance Health made up 0.16% of SwitchPoint Financial Planning's portfolio in Q2 2026, its #54 holding.
  • SwitchPoint Financial Planning first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • SwitchPoint Financial Planning's Elevance Health position peaked at $302K in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on SwitchPoint Financial Planning's 13F filing for Q2 2026, filed 17 Aug 2026.